Reliv International, Inc. (NASDAQ:RELV) a maker of nutritional supplements that promote optimal health, on March 5 reported its financial results for the fourth quarter and full year of 2013. Reliv International, Inc. (NASDAQ:RELV) stock performance was 2.05% in last session and finished the day at $2.02. Traded volume was 38,868.00 shares in the last session and the average volume of the stock remained 11,999.00 shares. … Continue reading Biotech Unusual Volume: Reliv International (NASDAQ:RELV), Transcept Pharmaceuticals (NASDAQ:TSPT), Aastrom Biosciences (NASDAQ:ASTM), Bacterin International Holdings (NYSEMKT:BONE)